Pierre Arsenault
Overview
Explore the profile of Pierre Arsenault including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan A, Arsenault P, Aw B, Brown V, Fox G, Grossman R, et al.
Can Fam Physician
. 2019 Sep;
65(9):625-633.
PMID: 31515311
Objective: To describe the burden of pneumococcal disease and associated risk factors in the Canadian adult population, delineate available pneumococcal vaccines and associated efficacy and effectiveness data, and review current...
2.
Arsenault P, Chiche D, Brown W, Miller J, Treister R, Leff R, et al.
Pain Rep
. 2019 Feb;
3(6):e696.
PMID: 30706039
Introduction: NEO6860 is a TRPV1 antagonist when activated by capsaicin but not by heat or pH, developed to relieve pain without the adverse events reported with non-modality-selective TRPV1 antagonists. Objective:...
3.
Arnold L, Arsenault P, Huffman C, Patrick J, Messig M, Chew M, et al.
Curr Med Res Opin
. 2017 Mar;
33(4):795-796.
PMID: 28276874
No abstract available.
4.
Buynak R, Rappaport S, Rod K, Arsenault P, Heisig F, Rauschkolb C, et al.
Clin Ther
. 2015 Oct;
37(11):2420-38.
PMID: 26428249
Purpose: Tapentadol extended release (ER) has demonstrated efficacy and safety for the management of moderate to severe, chronic pain in adults. This study evaluated the long-term safety and tolerability of...
5.
Arnold L, Sarzi-Puttini P, Arsenault P, Khan T, Brown P, Clair A, et al.
J Rheumatol
. 2015 Jun;
42(7):1237-44.
PMID: 26034150
Objective: To assess pregabalin efficacy and safety in patients with fibromyalgia (FM) with comorbid depression taking concurrent antidepressant medication. Methods: This randomized, placebo-controlled, double-blind, 2-period, 2-way crossover study was composed...
6.
Arnold L, Arsenault P, Huffman C, Patrick J, Messig M, Chew M, et al.
Curr Med Res Opin
. 2014 May;
30(10):2069-83.
PMID: 24867298
Objective: Safety and efficacy of a once daily controlled-released (CR) formulation of pregabalin was evaluated in patients with fibromyalgia using a placebo-controlled, randomized withdrawal design. Research Design And Methods: This...
7.
Delisle S, Terzi N, Ouellet P, Bellemare P, Tetrault J, Arsenault P
Respir Care
. 2012 Oct;
58(5):745-53.
PMID: 23107599
Objective: To compare the influence of 2 ventilation strategies on the occurrence of central apneas. Methods: This was a prospective, comparative, crossover study with 14 unsedated subjects undergoing weaning from...
8.
Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, et al.
J Rheumatol
. 2011 Oct;
38(12):2643-52.
PMID: 21965636
Objective: To evaluate the efficacy and safety of pregabalin monotherapy versus placebo for symptomatic pain relief and improvement of patient global assessment in patients with fibromyalgia (FM) enrolled from countries...
9.
Delisle S, Ouellet P, Bellemare P, Tetrault J, Arsenault P
Ann Intensive Care
. 2011 Sep;
1(1):42.
PMID: 21955588
Background: Mechanical ventilation seems to occupy a major source in alteration in the quality and quantity of sleep among patients in intensive care. Quality of sleep is negatively affected with...
10.
Delisle S, Francoeur M, Albert M, Ouellet P, Bellemare P, Arsenault P
Respir Care
. 2011 Feb;
56(10):1500-5.
PMID: 21310112
Background: The available predictors of spontaneous-breathing-trial (SBT) success/failure lack accuracy. We devised a new index, the CORE index (compliance, oxygenation, respiration, and effort). Objective: To compare the CORE index to...